Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 5:27 pm Purchase |
2020-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Atlas Venture Fund X, L.P. | 7,948,982 17.900% |
7,948,982 (New Position) |
Filing History |
| 2021-02-16 5:25 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
Atlas Venture Fund X, L.P. | 401,505 8.900% |
401,505 (New Position) |
Filing History |
| 2020-09-17 4:50 pm Sale |
2020-09-15 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X, L.P. | 2,524,866 6.300% |
-436,607 (-14.74%) |
Filing History |